SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Derivative Liability, Noncurrent
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) had Derivative Liability, Noncurrent of $35.75 thousand as of 2026-06-30, per its 10-Q filed 2026-09-24.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DerivativeLiabilitiesNoncurrent · last filed 2026-09-24
- 2026-06-30: Derivative Liability, Noncurrent $35.75K.
- 2026-03-31: Derivative Liability, Noncurrent $23.42K.
- 2025-12-31: Derivative Liability, Noncurrent $99.69K.
- 2025-09-30: Derivative Liability, Noncurrent $8.54K.
| Period end | Derivative Liability, Noncurrent |
|---|---|
| 2026-06-30 | $35.75K 10-Q · filed 2026-09-24 |
| 2026-03-31 | $23.42K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $99.69K 10-Q · filed 2026-09-24 |
| 2025-09-30 | $8.54K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $10.96K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $22.64K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $25.28K 10-K · filed 2026-03-31 |
| 2024-09-30 | $74.11K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $359.92K 10-Q · filed 2024-09-04 |
| 2024-03-31 | $214.62K 10-Q/A · filed 2024-09-04 |
| 2023-12-31 | $414.51K 10-K · filed 2025-02-26 |
| 2023-09-30 | $512.83K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $955.73K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $1.39M 10-Q · filed 2023-05-25 |
| 2023-01-31 | $1.19M 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |